ATE267010T1 - Sulfonfluoride zur behandlung von der alzheimerischen krankheit - Google Patents

Sulfonfluoride zur behandlung von der alzheimerischen krankheit

Info

Publication number: ATE267010T1
Authority: AT; Austria
Prior art keywords: treatment; individual; disease; alzheimer; fluorides
Prior art date: 1996-08-28

Application number

AT97938628T

Other languages

English (en)

Inventor

Donald Eugene Moss

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-28

Filing date

1997-08-26

Publication date

2004-06-15

1997-08-26 Application filed by Univ Texas filed Critical Univ Texas

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE267010T1 publication Critical patent/ATE267010T1/de

Links

208000024827 Alzheimer disease Diseases 0.000 title abstract 2
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 title 1
150000003457 sulfones Chemical class 0.000 title 1
KNWQLFOXPQZGPX-UHFFFAOYSA-N methanesulfonyl fluoride Chemical compound CS(F)(=O)=O KNWQLFOXPQZGPX-UHFFFAOYSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
230000003931 cognitive performance Effects 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT97938628T 1996-08-28 1997-08-26 Sulfonfluoride zur behandlung von der alzheimerischen krankheit ATE267010T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08705858 US5798392C1 (en)	1996-08-28	1996-08-28	Sulfonyl fluorides for the treatment of alzheimer's disease
PCT/US1997/015024 WO1998008497A1 (en)	1996-08-28	1997-08-26	Sulfonyl fluorides for the treatment of alzheimer's disease

Publications (1)

Publication Number	Publication Date
ATE267010T1 true ATE267010T1 (de)	2004-06-15

Family

ID=24835244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97938628T ATE267010T1 (de)	1996-08-28	1997-08-26	Sulfonfluoride zur behandlung von der alzheimerischen krankheit

Country Status (8)

Country	Link
US (1)	US5798392C1 (de)
EP (1)	EP0921790B1 (de)
JP (1)	JP2000517317A (de)
AT (1)	ATE267010T1 (de)
AU (1)	AU731755B2 (de)
CA (1)	CA2264582C (de)
DE (1)	DE69729201T2 (de)
WO (1)	WO1998008497A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030045005A1 (en) *	2000-10-17	2003-03-06	Michael Seul	Light-controlled electrokinetic assembly of particles near surfaces
WO2002062963A2 (en) *	2001-02-08	2002-08-15	Nps Pharmaceuticals, Inc.	Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
US8618167B2 (en) *	2001-11-06	2013-12-31	Board Of Regents, The University Of Texas System	Methods of attenuating cognitive deficits with sulfonyl fluorides
US20100256243A1 (en) *	2009-04-03	2010-10-07	Federica Pericle	Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl Fluorides
US8349376B1 (en) *	2011-03-08	2013-01-08	Bezzek Mark S	Anti-dementia regimen
US8846061B1 (en)	2011-03-08	2014-09-30	Mark S. Bezzek	Multivitamin-mineral regimens for longevity and wellness
EP3628315A1 (de)	2018-09-28	2020-04-01	Université de Caen Normandie	Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten
JP2024512659A (ja) *	2021-04-01	2024-03-19	アール．ピー．シェーラーテクノロジーズ，エルエルシー	医薬製剤におけるアニオン性キレート剤としてのリン脂質

1996
- 1996-08-28 US US08705858 patent/US5798392C1/en not_active Expired - Lifetime
1997
- 1997-08-26 CA CA002264582A patent/CA2264582C/en not_active Expired - Fee Related
- 1997-08-26 AU AU40915/97A patent/AU731755B2/en not_active Ceased
- 1997-08-26 EP EP97938628A patent/EP0921790B1/de not_active Expired - Lifetime
- 1997-08-26 JP JP10511856A patent/JP2000517317A/ja active Pending
- 1997-08-26 WO PCT/US1997/015024 patent/WO1998008497A1/en not_active Ceased
- 1997-08-26 AT AT97938628T patent/ATE267010T1/de not_active IP Right Cessation
- 1997-08-26 DE DE69729201T patent/DE69729201T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2264582C (en)	2009-01-06
US5798392A (en)	1998-08-25
WO1998008497A1 (en)	1998-03-05
EP0921790A1 (de)	1999-06-16
AU731755B2 (en)	2001-04-05
JP2000517317A (ja)	2000-12-26
US5798392C1 (en)	2002-06-04
AU4091597A (en)	1998-03-19
DE69729201D1 (de)	2004-06-24
DE69729201T2 (de)	2005-04-21
EP0921790A4 (de)	2000-11-02
CA2264582A1 (en)	1998-03-05
EP0921790B1 (de)	2004-05-19

Similar Documents

Publication	Publication Date	Title
KR950002785A (ko)	1995-02-16	골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
DE68919358D1 (de)	1994-12-15	Zusammensetzung zur behandlung der schizophrenie.
DE69815122D1 (de)	2003-07-03	Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
ATE140388T1 (de)	1996-08-15	Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
AU1049788A (en)	1988-06-30	Methods and peptides for the treatment of non-ige-mediated diseases
IL81573A (en)	1991-04-15	Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
DE69424777D1 (de)	2000-07-06	3,4-diarylchromane zur behandlung von dermatitis
HUP9900511A2 (hu)	1999-07-28	Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás
ATE267010T1 (de)	2004-06-15	Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DE69625682D1 (de)	2003-02-13	Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE225177T1 (de)	2002-10-15	Verwendung von (+)mefloquine zur behandlung von malaria
EA200000242A1 (ru)	2000-08-28	Применение фанхинона для лечения болезни альцгеймера
PT754054E (pt)	2002-10-31	Proteina anti-restenose
DE69111974D1 (de)	1995-09-14	Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
BR9508021A (pt)	2004-04-20	Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
DE69739482D1 (de)	2009-08-13	Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
EA200401295A1 (ru)	2005-02-24	Статиновая терапия для усиления поддержания когнитивной функции
DE69307702D1 (de)	1997-03-06	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
TR199801801T2 (xx)	1998-12-21	Madde k�t�ye kullan�m�n�n tedavisi.
NO961180L (no)	1996-03-22	Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
ATE350026T1 (de)	2007-01-15	Erhaltung von körpereigenen proteinen
UA9522A (uk)	1996-09-30	Спосіб лікування аутоімунного тиреоідиту
MY110416A (en)	1998-05-30	Composition for the treatment of schizophrenia.

Legal Events

Date	Code	Title	Description
2004-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties